Lavipharm S.A. Logo

Lavipharm S.A.

ISIN: GRS246003008 | Ticker: LAVI | LEI: 213800LWG2L246NHUF87

About Lavipharm S.A.

Company Description

Established in 1911, Lavipharm is today an integrated group of companies engaged in the research, development, manufacturing, import, marketing and sales, wholesaling and 3PL of pharmaceutical, dermocosmetic and healthcare products in Greece, with a strong international activity.

Our key features:

▪ Strong global player in pharmaceutical technologies with expertise on transdermal drug delivery systems
▪ Focus on international expansion
▪ Partner of choice for major international pharmaceutical and consumer health companies in Greece and abroad
▪ An innovator in specialty pharmacy services establishing a dynamic network across Greece
▪ Well-positioned for short, medium and long term growth

Year founded

1911

Served area

Worldwide

Headquarters

AG. Marinas 12, 19002 Peania Attica – Greece

Filings & Publications

Shareholder information

Shares outstanding

187,615,245

IPO

Nov. 8, 1995

Stock exchange(s)

Athens Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.